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Fine Needle Aspiration of the Thyroid: 
A Cytohistologic Correlation and Study of Discrepant Cases
Lourdes R. Ylagan,1 Tunde Farkas,2 and Louis P. Dehner1
Objective: Fine needle aspiration (FNA) is a reliable method in the initial assessment of thyroid nodules. The
purpose of this study was to evaluate the causes for discordance between the interpretation on FNA and the
pathologic findings in the resected thyroid. Methods: A computer search of all thyroidectomy specimens with
previous FNA from January 1998 to December 2001 was obtained from the files of the Lauren V. Ackerman
laboratory of surgical pathology, Barnes-Jewish Hospital. Excluded from the study were those FNAs performed
for suspected and confirmed metastatic disease to the thyroid as well as those cases unavailable for review. A
total of 45 FNA cases were identified with cytologic and histologic discrepancies. Results: Of the 1253 individ-
ual thyroid FNA performed during the study period, 255 patients (20%) subsequently had an open surgical
procedure on the thyroid. Of those who underwent surgery, 196 cases (77%) were concordant, whereas 45 pa-
tients (18%) were discordant, and 14 cases were excluded due to unavailability of slides for review (for exam-
ple, returned consult slides). The causes of the 45 discordant cases were: 20 cases (44%) were unsatisfactory for
diagnosis, 14 cases (31%) were due to interpretation error (false positive), and 11 cases (24%) were due to sam-
pling error (false negative). Conclusions: The most common causes of our discrepant cases are those whose FNA
diagnosis was interpreted as “unsatisfactory for diagnosis,” in 20 (7.8%) of 255 surgical cases. The false nega-
tive rate due to sampling error in 11 (4%) of 255 cases was mainly due to the presence of microscopic papil-
lary thyroid carcinoma (PTC); the false positive rate was due to interpretation error in 14 (6%) of 255 cases, and
those were explained by the occurrence of overlapping cytologic features among adenomatous nodules, follic-
ular neoplasms, the follicular variant of PTC, and Hashimoto’s thyroiditis.
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Introduction
FINE NEEDLE ASPIRATION (FNA) of the thyroid has becomethe most noninvasive, cost-effective, and efficient method
of differentiating benign and malignant thyroid nodules (1).
It has a high degree of proven sensitivity and specificity but
with a false negative interpretation that averages from 1 to
6% (2,3). According to the Papanicolaou Society of Cy-
topathology Task Force on Standards of Practice, a false 
negative (FN) rate not to exceed 2% and a false positive (FP)
rate of no more than 3% are regarded as benchmarks that
should be achieved on FNA cytology of the thyroid (4). This
study, as several others in the recent past, has not reached
the level of sensitivity and specificity proposed by the task
force. We tried to identifiy the causes of our discrepant 
cytologic/histopathologic cases and to identify our FN and
FP rates in a patient population where 20% of all patients
with prior thyroid FNA underwent a total or subtotal resec-
tion of the thyroid gland.
Materials and Methods
A computer search of all FNA of the thyroid from Janu-
ary 1998 to December 2001 was performed at Barnes-Jewish
Hospital, Washington University Medical Center, St. Louis,
Missouri. During this four-year period, 1253 FNA of the thy-
roid were performed. These cases included FNA of the 
thyroid performed by radiologists (ultrasound guidance), cy-
topathologists (by palpation), and clinicians (by palpation).
Of these, 255 patients (20% of the total series of 1253 cases)
went to surgery and provided the opportunity for cytologic-
histopathologic correlation. Of those, 196 (77% of 255 cases)
had cytologic-histopathologic correlation. There were 45
cases (18% of 255 cases) with cytologic-histopathologic dis-
crepancies and 14 cases were excluded due to unavailability
of slides for review (returned slides from consultation cases).
A total of 45 cases from 45 patients formed the basis for this
study (Figs. 1 and 2).
Each patient underwent three separate FNAs, for which
1The Lauren V. Ackerman Laboratory of Surgical Pathology, Department of Pathology and Immunology, Washington University Med-
ical Center, St. Louis, Missouri; 2Department of Pathology, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania.
two smears and four slides were prepared from each aspi-
rate. Air dried smears were stained with DiffQuik1 Dade
Behring Newark, DE and alcohol-fixed smears were stained
with the Papanicolaou stain. A total of 12 initial slides were
made for each patient. When a repeat procedure is necessary
for an initial unsatisfactory aspirate, two additional FNAs
are done from which two smears and four slides are addi-
tionally made. Some clinicians, however, elect not to repeat
an “unsatisfactory” aspirate.
The cytologic and histologic sections were reviewed.
Causes of our false negative and false positive cases were
evaluated and rates were calculated. These rates were de-
termined on the basis of definitions established by the Pa-
panicolaou Society of Cytopathology (4). Accordingly, a
false-negative diagnosis was defined as a cytologic interpre-
tation of a non-neoplastic lesion which would otherwise not
have had required surgical excision, yet the resection re-
vealed a malignant lesion. A false-positive diagnosis has
been defined as a cytologic diagnosis of a neoplasm requir-
ing surgical excision, but revealed to be a non-neoplastic le-
sion in the surgical resection (4). These rates are then com-
pared to several prior series of thyroid FNA.
Cases with inadequate cytologic samples were not included
in the calculation of false-negative cases as these cases were
interpreted as “unsatisfactory for diagnosis” and were all re-
ported to the clinicians and radiologists as “preliminary” di-
agnoses. A repeat FNA is always suggested or offered to the
patient for an initial “unsatisfactory for diagnosis.” A mini-
mum requirement of 6 to 8 follicular groups with 8–10 follic-
ular cells per group in at least 2 separate aspirates were used
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FIG. 1. Of the 1253 cases of thyroid FNA performed at our institution over a period of 4 years, 255 (20%) were taken to
surgery. One-hundred-ninety-six (77%) had cytohistologic correlation and 45 (18%) had cytohistologic discrepancies. Four-
teen cases were excluded due to unavailability of slides for review. This rate has not significantly changed over the 4 years.
FIG. 2. Flow chart of cases with cytologic-histopatholgic correlation.
for assessment of adequacy in all thyroid FNA samples per
site (5). Although an aspirate lacking follicular epithelium can
be interpreted as benign colloid nodules in the presence of
abundant colloid, aspirates containing only blood in the ab-
sence of colloid are considered “unsatisfactory” (6).
The diagnostic categories used at our institution are: “neg-
ative for malignancy” for an unequivocal diagnosis of non-
neoplastic lesions such as nodular hyperplasia, colloid nod-
ules, and Hashimoto’s thyroiditis; “atypical cytology” for
follicular lesions with a differential diagnosis of follicular
neoplasm or which carry other cytologic features that are in-
determinate for neoplasm; “suspicious for malignancy” for
cases with rare cells with cytologic features of papillary,
medullary or anaplastic thyroid carcinoma; and positive for
malignancy- for cases with abundant cells with unequivocal
cytologic features of the same malignant neoplasms includ-
ing other variants of PTC. A comment section is added if a
differential diagnosis is provided in any one of these cate-
gories. Most surgeons have elected to operate on those cases
with a threshold interpretation of “atypical cytology” in our
institution.
Results
Of the 45 cases in our final study group, 20 (43%) were
“unsatisfactory for diagnosis”; eleven of these 20 (55%) cases
were performed by clinicians, seven (35%) were performed
by radiologists and two (10%) by cytopathologists. Only two
cases were repeated (still unsatisfactory on the second at-
tempts). All of these patients went to surgery after an “un-
satisfactory” interpretation. The ultimate histopathologic di-
agnosis in these cases included nodular hyperplasia or
goitrogenous thyroid (11 cases, 55%), PTC (4 cases, 20%), fol-
licular adenoma (3 cases, 15%), Hashimoto’s thyroiditis (1
case, 5%), and Grave’s disease (1 case, 5%) (Table 1). The un-
satisfactory rate at our institution when a strict criteria of ad-
equacy is applied is 7.8% (n 5 255).
Eleven discrepant cases were on the basis of sampling 
error. Most sampling errors were due to the presence of 
a micropapillary thyroid carcinoma not sampled during 
the FNA. These cases included: micropapillary carcinoma
(PTC , 0.9 cm in diameter) (5 cases), PTC, classic pattern (3
cases), follicular variant of PTC (2 cases), and follicular car-
cinoma (1 case) (Table 2). Two cases of the follicular variant
of PTC only showed rare nuclear grooves on rare cells which
was a cause of a FN diagnosis (Fig. 3). There was abundant
colloid in the background.
The remaining 14 cases represented interpretation errors:
all 14 cases were benign processes whose features mimicked
or suggested a neoplasm: Hashimoto’s thyroiditis (5 cases),
nodular hyperplasia (3 cases), Hurthle cell changes within
nodular hyperplasia (3 cases) and follicular adenoma (3
cases) (Table 3).
Four of five cases diagnosed as follicular neoplasms were
found to be due to Hashimoto’s thyroiditis. The cytologic di-
agnosis of follicular neoplasm was made on the basis of find-
ing follicles in a background of obscuring blood in four cases
and in only one case were there lymphocytes and plasma
cells in the aspirates. In cases for which a diagnosis of atyp-
ical cytology (3 cases), PTC or suspicious for PTC (3 cases),
or Hurthle cell neoplasm (2 cases) was made on the basis of
finding nuclear grooves in some of the cells and in some
Hurthle cells with a concomitant absence of colloid (Fig. 4).
One case diagnosed as a follicular neoplasm which was even-
tually found to be nodular hyperplasia was based on the
presence of numerous follicles and lack of colloid on the as-
pirate. This was in part due to sampling.
The false positive and false negative rates are calculated
at 6% and 4%, respectively, on the basis of these findings.
FINE NEEDLE ASPIRATION 37
TABLE 1. HISTOLOGIC DIAGNOSES OF CASES SIGNED-OUT AS
“UNSATISFACTORY FOR DIAGNOSIS”
Number of cases
(n 5 20) Percent Histologic diagnosis
11 55% Nodular hyperplasia
4 20% Papillary thyroid carcinoma
3 15% Follicular adenoma
1 5% Hashimoto’s thyroiditis
1 5% Graves’ disease
TABLE 2. CAUSES OF OUR “FALSE NEGATIVE” CASES (SAMPLING ERROR)
Number of cases
(n 5 11) Cytologic diagnosis Histologic diagnosis
5 Nodular hyperplasia Micropapillary TC (1 mm)
Nodular hyperplasia Micropapillary TC (0.9 and 0.5 cm)
Nodular hyperplasia Micropapillary TC (1 mm)
Follicular lesion Micropapillary TC (1 mm)
Hemorrhagic cyst Micropapillary TC (6 mm)
3 NH with Hürthle cell change PTC
Hürthle cell lesion PTC arising in a Hashimoto’s thyroiditis
Nodular hyperplasia PTC
2 Follicular lesion Follicular variant of PTC
Parathyroid tissue sampled Follicular variant of PTC
1 Nodular hyperplasia Follicular carcinoma
PTC, papillary thyroid carcinoma; NH, nodular hyperplasia; TC, thyroid carcinoma.
This calculation is based only on those cases for which there
is a confirmatory histopathology.
Discussion
Detection of most PTC, medullary, anaplastic and, in some
cases, insular carcinomas of the thyroid on FNA can be done
with a degree of sensitivity and specificity (7).2 However, a
small proportion of cases qualify for the categories of “false
positive” and “false negative” due to the nature of the le-
sion, intrinsic limitations of the procedure, and in most in-
stances, the manner, skill, and experience of the individual
operators. Every effort should be made to evaluate the var-
ious individual group practices, to determine whether one’s
results are comparable to national standards and to ascer-
tain whether other methods of practice have affected these
reported values.
One national cytopathology society has published guide-
lines for the standards of practice in FNA cytology of the
thyroid (4). These guidelines suggest that a false negative
(FN) and false positive (FP) rate of less than 2% and 3%, re-
spectively, should be achieved. These rates were based on
several studies published from 1980–1993 (8–15). More re-
cent studies, specifically looking at the individual institu-
tion’s causes of FN and FP cases, have reported higher and
possibly more current realistic rates (9,16–21). This could be
a reflection of a higher frequency of surgical excisions of thy-
roid nodules status-post FNA in recent years as indicated by
the fact that approximately 20% of all cases come to resec-
tion of a thyroid nodule after an FNA procedure whereas it
has only been 10% or so in the past (Table 4).
Individual FP and FN rates have also increased in more
recent series (9,16–21). These values have trended upward,
especially in the category of FP diagnoses. The causes of this
increase in FP diagnoses can be due to the existence of over-
lapping cytologic features among follicular neoplasms, ade-
nomatous nodules, lymphocytic thyroiditis and some follic-
ular variants of PTC that were less well appreciated in the
past. The presence of nuclear grooves among Hurthle cells
in some cases of chronic lymphocytic thyroiditis and nodu-
lar hyperplasia is the most frequent cause of FP cases in our
series. Overlapping cytologic features can also be seen be-
tween nodular hyperplasia and “follicular lesions” for which
the differential diagnosis includes a follicular neoplasm, es-
pecially if the aspirate does not yield abundant colloid. In
five of our cases which showed Hashimoto’s thyroiditis on
final histopathology, the presence of lymphocytes were only
appreciated on FNA in one case which was also bloody and
shows absence of colloid. In cases for which an FNA diag-
nosis of neoplasm such as PTC, follicular neoplasm and
Hurthle cell neoplasm, the histopathologic diagnosis was
nodular hyperplasia in three cases, Hurthle cell adenoma in
three cases and follicular adenoma in three cases. This oc-
curred because of presence of nuclear grooves and con-
comitant absence of colloid in the aspirates. Therefore, the
presence of nuclear grooves with a concomitant absence of
colloid are non-specific features which can be seen in cases
of Hashimoto’s thyroiditis, nodular hyperplasia with onco-
cytes, follicular adenoma, and Hurthle cell adenoma. These
features were also observed by Settakorn, and associates, for
which differentiating features between an adenomatous goi-
ter versus follicular neoplasm, adenomatous goiter versus
PTC, and thyroiditis versus follicular neoplasm can be
demonstratively difficult and confounding (17). These ob-
servations and problems are consistent with our own expe-
rience. Similar difficulties in the differentiation of adenoma-
toid nodules, follicular neoplasms and the follicular variant
of PTC were also observed by Sidawy et al. (7).
In the FN category, the most common cause in our series
is the presence of an unsampled microcarcinoma in the set-
ting of an adenomatous goiter. These PTCs usually measures
less than 1 cm in diameter. Four of our cases have been in-
cidental micronodules for which the target lesion is some-
thing other than the incidental PTC. One of the cases, how-
ever, was an unsampled 0.9 cm nodule in a non-ultrasound
guided FNA of an adenomatous goiter. Some pathologists
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TABLE 3. CAUSES OF OUR “FALSE POSITIVE CASES” (INTERPRETATION ERRORS)
Number of cases
(n 5 14) Cytologic diagnosis Histologic diagnosis
5 Follicular neoplasm Hashimoto’s thyroiditis
Follicular neoplasm Hashimoto’s thyroiditis
Follicular neoplasm Hashimoto’s thyroiditis
Follicular neoplasm Hashimoto’s thyroiditis
AC due to NG Hashimoto’s thyroiditis
3 PTC Nodular hyperplasia
Follicular neoplasm Nodular hyperplasia
AC due to NG Nodular hyperplasia
3 AC, Hashimoto’s thyroiditis Hurthle cell adenoma
Follicular neoplasm, HC type Hurthle cell metaplasia in NH
Hurthle cell neoplasm Hurthle cell metaplasia in NH with infarction
3 PTC Follicular adenoma
AC due to thick colloid Follicular adenoma
Suspicious for PTC Follicular adenoma
AC, atypical cytology; NG, nuclear grooves; PTC, papillary thyroid carcinoma; NH, nodular hyperplasia; HC, Hurthle cell.
FIG. 3. Nuclear grooves, a rare feature of the follicular variant of papillary thyroid carcinoma, as a cause of a false nega-
tive finding. A: Most of the aspirate showed follicles with small round nuclei (4003, Papanicolaou stain). B: Rare cells show
distinct nuclear grooves (arrow) but without intranuclear inclusions (10003, Papanicolaou stain).
FIG. 4. Nuclear grooves, a non-specific feature, as a cause of false positive finding in a case of nodular hyperplasia, but
also seen in Hashimoto’s thyroiditis, follicular adenoma, and Hürthle cell adenomas. A: Note presence of a macrophage
(arrow) in a case of a hyperplastic nodule (10003, Papanicolaou stain). B: An abundance of nuclear grooves in the aspirate
(arrows) (10003, Papanicolaou stain).
TABLE 4. COMPARISON OF THE DISCREPANCY RATES OF FNA OF THE THYROID
Total thyroid Total with Study Unsat Discrepancy False False
FNA surgical F/U period rate rate positive negative
Author (Ref) Year n n (%) (years) % % % %
Current study present 1253 255 (20) 4.0 7.8 18 6.0 ,4.0
Mitra (15) 2002 N/R 100 (20) N/R N/R 25 5–6 1–17
Yang (20) 2001 1135 175 (15) 4.0 0.7 N/R 10.0 ,0.0
Settakorn (16) 2001 1761 415 (24) 4.0 22.0 N/R 16.7 ,6.3
Cappel (17) 2001 1020 231 (23) 10.0 20.0 2 20.0 ,1.0
Bakhos (21) 2000 N/R 625 (20) 13.0 7.0 12 8.0 ,4.0
Baloch (18) 1998 662 140 (21) 3.5 11.0 N/R 16.0 ,7.5
Sidawy (19) 1997 N/R 133 (20) 4.3 8.3 27 10.0 ,1.0
Hall (8) 1989 795 72 (9) 5.0 8.3 20 17.0 ,3.0
FNA, fine needle aspiration; N/R, not reported; F/U, follow-up; Unsat, unsatisfactory for diagnosis.
do not consider these “incidental nodules” as true “false neg-
ative” cases, as their nature can only be proven to be “false
negative” if they are truly clinically significant lesions on sur-
gical excision (22). However, some of these “microcarcino-
mas” can be clinically meaningful lesions as shown by Yang
and colleagues in their series (23).
Another cause of the “false negative” lesion is due to the
subtle cytologic features of PTC on FNA in the setting of the
follicular variant. Indeed, one of our cases, showed cytologic
features which were not typical of PTC with slightly enlarged
cells with rare nuclear grooves as the only findings. Thick
dense colloid and macrophages were seen in the back-
ground. Baloch and associates repeated a similar experience
in four of their FN cases (19). Several others have also ob-
served that the follicular variant of PTC usually present as
monolayer sheets or synctitial fragments with a paucity of
the classic nuclear features of papillary carcinoma which can
present as a pitfall in the cytologic evaluation of these thy-
roid nodules (20,24,25). Therefore, although presence of nu-
clear grooves can be non-specific as mentioned previously,
it can be the only diagnostic clue in some cases of PTC for
which the other typical cytomorphologic feature of nuclear
inclusions as in the follicular variant, are rarely seen or lack-
ing altogether. These difficulties in FNA interpretation of fol-
licular variant of PTC are not encountered to the same de-
gree in the histopathologic diagnosis.
In our “unsatisfactory for diagnosis” category, we found
four of 20 cases (25%) to be of the classic PTC and three (15%)
follicular adenomas in the final histopathologic interpreta-
tion. This highlights the importance of a repeat procedure in
all cases for which an “unsatisfactory for diagnosis” is ren-
dered. When evaluated as to the causes of these unsatisfac-
tory specimens, all cases showed only blood without follic-
ular epithelium. Eleven of those cases were performed by
clinicians, seven by radiology residents and two by cy-
topathologists. In the latter two cases, repeat aspirates again
showed blood only. The final histopathologic finding was a
1.5 cm and a 9 cm classical PTC, respectively. Gross findings
of the 9 cm mass showed a multicystic lesion with numer-
ous papillary excrescences which were not sampled by FNA.
When a clinician is in the habit of requesting an “adequacy
of sampling” in their thyroid FNAs, the unsatisfactory in-
terpretation should not be included in the category of a “false
negative” diagnosis, as it is a non-diagnosis. All of the “un-
satisfactory or inadequate” samples should be re-sampled
before any definitive surgery is attempted. Educating our
clinical colleagues as to the proper interpretation of these re-
sults would be helpful in the final outcome.
In summary, individual group practices play a role in
achieving what the appropriate rates are for their practices.
We are responsible for educating our clinical colleagues in
the importance of obtaining an adequate sample in any FNAs
but most specially in thyroid FNAs as true evaluation of false
negative rates can be achieved only after years of clinical fol-
low-up. The FP and FN rates are actually higher than the
recommended values set by the Papanicolaou Task Force on
Standards of Practice, but more recently remains within
range from institution to institution.
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